Share This Page

Begone 2020: Despite COVID, Alzheimer’s Research Advanced

ALZFORUM: Last year, people with dementia were most vulnerable, and this constrained research. Investigators adjusted and managed to make strides in important areas, from plasma tests for Aβ and tau to therapeutics. 2020 saw the first — if embattled — FDA filing for a new AD drug since 2003. If approved, it would be the first biologic treatment for this disease.


Last year was a year to remember. (Or make that a year to forget!) Hope held until February that SARS-CoV-2 might be contained, but was quickly dashed when the virus spread across the globe. Lockdowns, social isolation, protective equipment shortages, and heartbreak became the norm as millions of people became infected and the death toll soared, especially among the old.

People with dementia were most vulnerable, and this constrained research. Clinical studies and trials were hampered because in-person visits had to be cancelled or rescheduled. Basic research was disrupted. Laboratories worldwide were forced to shutter or curtail access, putting projects on ice and precious cell and animal lines in jeopardy. Conference organizers scrambled to reschedule or switch to an online format, with various degrees of success. Casualties included the Society for Neuroscience annual meeting. Typically drawing up to 30,000 scientists annually, it was cancelled.

By June, investigators had adjusted and research began to get mostly back on track.

Some clinical trials were abandoned (Jun news), but even so, as outlined in this yearly research roundup, the field overall managed to make strides in important areas, from plasma tests for Aβ and tau to therapeutics. Twenty-twenty saw the first—if embattled—FDA filing for a new AD drug since 2003. If approved, it would be the first biologic treatment for this disease.

Read the complete article at AlzForum.org.

Related:

Email me when people comment
Notify of
guest

0 Comments
Inline Feedbacks
View all comments
Edited by:
Picture of P. Berger

P. Berger

This site was inspired by my Mom’s autoimmune dementia.

It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.

The site is dedicated to all those preserving the dignity of the community of people living with dementia.

Peter Berger, Editor

Share this page To

You May LIke:

Prevention

Why Time with Friends Impacts Dementia

SOCIALIZING in your 50s and 60s strongly predicts less dementia later on. Learn why, from new research by University College London. See Ohio State University demonstrate how true it is, from animals to people.

Read More »
Share to Facebook
Twitter
LinkedIn

This site was inspired by my Mom’s autoimmune dementia.

It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.

The site is dedicated to all those preserving the dignity of the community of people living with dementia.

Peter Berger, Editor

Visit Alzheimer's Weekly On

0
Would love your thoughts, please comment.x
()
x
News, Treatments, Care Tips, Diet

Alzheimer's & Dementia Weekly Newsletter: Free

Free. Care & Treatment. Research & Prevention

This site was inspired by my Mom’s autoimmune dementia.

It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. It has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.

The site is dedicated to all those preserving the dignity of the community of people living with dementia.

Peter Berger, Editor

News to Get at the Truth

Subscribe To Our Weekly Newsletter